Neonatal opioid withdrawal syndrome, unlike opioid withdrawal syndrome in adults, may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts
As an investigational agent, cagrilintide could become an essential tool in the comprehensive management of metabolic disorders
As a result, various formulations have been developed, including film-coated tablets, capsules, powders, liquid solutions, and chewable and palatable tablets designed to improve treatment adherence
Barkowsky, G
The subjective experience users consistently describe is not that food becomes unappealing, but that the urgency around eating disappears
People now focus on their health because they want to protect themselves from diseases that emerged after the pandemic